Every Botox injection and every filler syringe administered in a med spa is the practice of medicine. When the person holding the syringe is not a physician — an RN, an NP, a PA — the act has been delegated. The legal question is not whether delegation happened, but whether it happened correctly: with the right agreement, the right supervision, the right documentation, and a chart audit trail that would survive a board complaint.
This article covers how practices build a delegation framework for injectables that holds up under regulatory scrutiny. It is for med spa owners, medical directors, and the providers who inject under delegated authority.
Why Delegation Protocols Fail
The most common enforcement actions against med spas are not triggered by bad outcomes. They are triggered by structural delegation failures:
- An RN injects without a patient-specific order or a qualifying standing order in the chart.
- A physician "supervises" by signing charts weeks after treatment, without ever examining the patient.
- Standing orders are so generic they authorize the RN to treat any patient with any dose — which boards interpret as the RN practicing independently.
- There is no written delegation agreement, or the one on file has not been updated since the injector was hired.
- The medical director has no documented competency evaluation for the procedures being delegated.
These failures share a root cause: the practice treated delegation as a formality rather than an active supervisory system.
The Legal Stack Under Delegation
Delegation of injectable procedures sits on three legal layers, all of which vary by state:
State medical practice act. Defines what constitutes the practice of medicine and who may perform medical acts. In every state, injecting prescription neurotoxins and dermal fillers is the practice of medicine.
State nursing and PA practice acts. Define what RNs, NPs, and PAs may do independently and what requires physician delegation or supervision. In most states, RNs cannot inject without a physician's order. NP and PA authority ranges from independent practice to required collaborative agreements.
Board advisory opinions and rules. State boards of medicine and nursing issue specific guidance on cosmetic procedure delegation. These carry enforcement weight even when they are not statutes.
Texas, for example, requires a written delegation agreement under Texas Medical Board rules (previously §193.17, restructured in 2025 into 22 Tex. Admin. Code §§169.25–169.27) for non-surgical cosmetic procedures, with a physician, PA, or APRN on-site or immediately available. California requires that a physician establish a genuine physician-patient relationship — including a history, exam, and treatment plan — before delegating injection tasks to an RN. New York requires a "good-faith examination" by a prescriber before any cosmetic injection is ordered for a new patient.
The framework below is structured to work across states. Adapt the supervision intensity and documentation requirements to your specific jurisdiction.
Delegation and Corporate Practice of Medicine
In states that enforce the Corporate Practice of Medicine (CPOM) doctrine — including California, New York, Texas, Florida, and Ohio — a non-physician cannot own a medical practice. Most med spas resolve this through a Management Services Organization (MSO) structure: a business entity owned by the non-physician investor provides administrative services (marketing, scheduling, billing, facilities) to a separate physician-owned medical entity (PC, PLLC, PA) that holds the medical license and employs or contracts with the medical director.
Delegation lives on the medical-entity side. The delegation agreement is between the supervising physician (or NP with prescriptive authority, where permitted) and the injecting provider. It is a clinical document, not a business document. The MSO cannot delegate medical acts — only a licensed provider can. Practices that blur this line — where the MSO effectively directs clinical operations, including staffing and treatment protocols — expose both the medical director and the business owner to enforcement risk.
The Written Delegation Agreement
Every injector who is not a physician should have a current, signed delegation agreement on file. This is a separate document from an employment contract or a job description. It specifies:
- Who is delegating. The physician (or, where state law permits, the NP with prescriptive authority) who holds clinical authority over the delegated acts.
- To whom. The specific licensee (RN, NP, PA) authorized to perform the delegated acts.
- Which procedures. A specific list — e.g., "administration of onabotulinumtoxinA (Botox) for cosmetic indications in the upper face" and "administration of hyaluronic acid dermal fillers (Juvéderm Ultra, Restylane Lyft) for cheek and nasolabial augmentation." Generic authorization ("all cosmetic injectables") is a red flag for boards.
- Supervision level. Direct (on-site), indirect (immediately available by phone or telemedicine), or general — matched to the state requirement for the specific procedure and provider type.
- Training and competency prerequisites. What training the injector must complete before delegation begins, and how ongoing competency is verified.
- Exclusions. Procedures the injector is explicitly not authorized to perform — e.g., tear-trough filler, nonsurgical rhinoplasty, or injection of any product the injector has not been trained on.
- Review and update schedule. At minimum annually, or whenever the injector's scope, the practice's formulary, or the supervisory arrangement changes.
Texas requires this document explicitly. Most other states expect it implicitly, and its absence is the first thing investigators ask for after a complaint.
Standing Orders vs. Patient-Specific Orders
Delegation operates through one of two mechanisms:
Patient-specific orders. The delegating physician (or NP/PA, where applicable) examines or reviews the patient and writes an individualized order specifying the product, area, and dose range. This is the safest delegation mechanism and is required in some states for RN injectors.
Standing orders (also called standardized procedures or protocols). Pre-approved treatment protocols that authorize the injector to treat patients who meet defined criteria without a separate physician order for each visit. Standing orders typically specify:
- Approved products and anatomical areas (e.g., "onabotulinumtoxinA for glabellar, frontalis, and lateral canthal lines").
- Dose ranges (e.g., "10–25 units per treatment area, total dose not to exceed 75 units per visit").
- Patient-selection criteria and contraindication screening requirements.
- Conditions that require physician consultation before treatment (e.g., pregnancy, autoimmune disease, prior adverse reaction, use of blood thinners).
- When a patient-specific exam or order is required regardless (e.g., new patients, patients returning after 6+ months, patients requesting treatment outside the standing-order scope).
Standing orders do not replace the initial patient evaluation. In most states, a physician or qualified provider must still perform an initial good-faith examination, develop a treatment plan, and document it in the chart before the injector proceeds under the standing order. The standing order authorizes the injector to execute the plan without a new order at each visit — it does not authorize the injector to create the plan independently.
Some states — including New York and California — have specific requirements about who can perform the initial exam and what it must include. Check your state board's current position.
The Good-Faith Examination
The initial patient evaluation is the gatekeeping step that separates lawful delegation from unlicensed practice. At minimum, the exam should document:
- Patient identity and demographics.
- Relevant medical history: prior cosmetic treatments, allergies, neuromuscular disease (for neurotoxins), bleeding disorders, pregnancy/breastfeeding status, current medications (anticoagulants, aminoglycosides, muscle relaxants).
- Focused anatomical assessment of the treatment area.
- Treatment plan: product, anatomical site, anticipated dose or volume range.
- Informed consent discussion documented in a separate consent form.
Who performs this exam depends on state law. In some states, only a physician may perform it. In others, an NP or PA with prescriptive authority can perform it and develop the treatment plan. The key is that the examiner is authorized — by license and by the delegation agreement — to do so.
The Chart: What Goes in Every Injection Visit
The treatment chart is the audit trail. It should contain enough detail that a board reviewer — or a malpractice attorney — can reconstruct exactly what happened, why, and under whose authority.
For each injection visit, the chart should document:
| Element | What to Record |
|---|---|
| Date and time | Visit date, injection time |
| Patient identity | Name, DOB, MRN |
| Examining/supervising provider | Name and credential of the provider who performed or authorized treatment |
| Injector | Name and credential of the person who administered the injection |
| Product and lot number | Brand name, specific product (e.g., "Juvéderm Voluma XC"), lot/serial number from the vial or syringe |
| Anatomical site | Specific injection site(s) — a facial diagram is standard |
| Dose or volume | Units (neurotoxins) or volume in mL (fillers) per site |
| Technique | Needle vs. cannula, injection depth where relevant |
| Anesthesia used | Topical, dental block, ice — or none |
| Adverse events observed | Bruising, swelling, pain — or "none observed" |
| Post-treatment instructions | Given verbally and in writing; document what was communicated |
| Follow-up plan | Scheduled follow-up date or "return as needed" with criteria for early return |
Lot-number documentation deserves special attention. In a counterfeit-product investigation or an adverse-event cluster, the lot number is the traceability link between the patient and the supply chain. Every injection chart should capture it.
Chart Audits: The Active Supervision Mechanism
A delegation protocol that delegates but never audits is not a supervisory system — it is a letter of marque. Regular chart audits are the mechanism by which the supervising physician confirms that:
- Treatment plans are being followed.
- Standing orders are applied within their authorized scope.
- Documentation is complete and defensible.
- Injectors are not drifting beyond their authorized procedures or dose ranges.
Audit frequency should be defined in the delegation agreement. A common cadence:
- New injectors: 100% chart review for the first 30–90 days.
- Established injectors: Random-sample audit of 5–10% of charts monthly, plus full review of any chart involving a complication or patient complaint.
- All injectors: Annual competency review with documented sign-off by the supervising physician.
Audit findings should be documented, shared with the injector, and kept in the injector's privileging file. Patterns — consistent over- or under-dosing, missing lot numbers, failure to document informed consent — are corrective-action triggers.
The Emergency Response Plan
Several states — including Texas, New Jersey, and New York — require or strongly recommend a written emergency response plan as part of the delegation framework. The plan should specify:
- How to recognize acute adverse events (anaphylaxis, vasovagal syncope, vascular occlusion, injection-site infection).
- Immediate interventions available in the treatment room (epinephrine auto-injector, hyaluronidase for filler occlusion, aspiration and positioning for syncope).
- When and how to activate emergency medical services (911).
- The chain of communication: injector → supervising physician → EMS → patient follow-up.
- Post-event documentation and incident review.
The emergency plan is not theoretical. If a patient experiences vascular occlusion from a filler injection and the injector cannot locate hyaluronidase or reach the supervising physician, the absence of a practiced emergency response plan becomes the centerpiece of the malpractice claim.
Competency and Privileging
Before an injector begins treating patients under a delegation agreement, the supervising physician should verify and document:
- Current, unrestricted license in the appropriate state and profession.
- Training specific to the products and procedures being delegated (completion certificates, CME records, preceptorship logs).
- Observed clinical competency: the physician directly observes the injector performing each delegated procedure on at least one patient and documents sign-off.
- Emergency readiness: the injector can recognize and initiate management of vascular occlusion, anaphylaxis, and other acute adverse events — and knows when to escalate to the supervising physician.
This is the privileging file. It should be updated at every annual review and whenever the injector's scope changes.
What Estheticians Cannot Do
In every U.S. state, estheticians cannot legally inject Botox, dermal fillers, or any prescription product. Injection constitutes the practice of medicine. Estheticians who inject face criminal charges for practicing medicine without a license, and the supervising provider faces board discipline for enabling unlicensed practice.
LPNs and LVNs are similarly restricted in most states. The American Med Spa Association's practice guidelines state that LPNs, LVNs, and unlicensed personnel "may not perform injectable treatments under any circumstances, regardless of any certification, training or direct supervision."
State-by-State Variables That Change the Framework
While the principles above are broadly applicable, three state-law variables change how a delegation protocol must be configured:
NP practice authority. In full-practice states (Arizona, Colorado, Oregon, Montana), NPs can evaluate, diagnose, and prescribe independently — including cosmetic injectables. In restricted-practice states (California, Florida, Georgia, Michigan), NPs need a collaborative practice agreement with a physician. The delegation structure changes depending on whether the NP is the delegator or the delegatee.
Supervision intensity. Some states require the supervising physician to be physically on-site when RNs inject (California). Others allow indirect supervision — the physician must be "immediately available" by phone (Texas). A few states are more permissive. The delegation agreement must match the state's supervision requirement for each provider type and procedure.
Standing-order legality. Not all states permit standing orders for cosmetic injections. Some require a patient-specific order for every visit. Verify your state board's current position before building a standing-order-based workflow.
Sources
- IAPAM, "Botox Certification by State: A Complete Regulatory Guide (2026)," https://iapam.com/botox-library/botox-certification-by-state
- Texas Medical Liability Trust, "Regulations for Medical Spas in Texas," https://www.tmlt.org/resource/regulations-for-medical-spas-in-texas
- AmSpa Practice Guidelines for Non-Invasive Medical Aesthetic Procedures, https://www.facialesthetics.org/wp-content/uploads/2020/10/amspa_practice_guidelines.pdf
- ByrdAdatto / Marti Law Group, "What Every Aesthetic Practice Needs to Know About Delegation Agreements," https://www.martilawgroup.com/post/aesthetic-practice-delegation-agreement
- MedSpa Standards, "Who Can Inject Botox in New York? RN, NP & PA Scope of Practice 2026," https://medspastandards.com/blog/new-york/who-can-inject-botox-new-york
- Cohen Healthcare Law, "Can Nurses Legally Open a Med Spa in California?" https://cohenhealthcarelaw.com/can-a-nurse-open-a-med-spa-in-california
- Kentucky Board of Nursing, AOS #35: Cosmetic and Dermatological Procedures by Nurses, https://kbn.ky.gov/KBN%20Documents/aos35-cosmetic-and-dermatological-procedures-by-nurses.pdf
- Arkansas State Board of Nursing, Position Statement 21-1: Role of the Licensed Nurse in the Practice of Aesthetics, https://healthy.arkansas.gov/wp-content/uploads/21-1RoleofLicensedNurseinPracticeofAesthetics.pdf
- ASDSA, "Medical Spa Safety Resources," https://www.asds.net/asdsa-advocacy/practice-affairs/medical-spa-safety-resources-a-comprehensive-overview
